Healthcare Services

Global Automation In Biopharma Industry Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

March 30, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Automation In Biopharma Industry Market At The End Of The 2026–2030 Forecast Period?

The market size for automation within the biopharma industry has experienced significant expansion in recent years. It is anticipated to increase from $2.19 billion in 2025 to $2.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. The historical growth in this sector is attributable to factors such as the increasing complexity of biologic drug production, a rising demand for scalable biopharma manufacturing, the early adoption of laboratory automation, the expansion of contract manufacturing services, and advancements in process control technologies.

The market for automation within the biopharma industry is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $3.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.7%. Several factors are driving this anticipated growth, including heightened investments in intelligent biomanufacturing plants, the increasing integration of continuous manufacturing processes, the broadening scope of personalized biologics production, a rising need for automation that adheres to regulatory standards, and a greater emphasis on enhancing manufacturing efficiency. Key trends expected during this period involve the wider implementation of robotic manufacturing platforms, the increasing incorporation of digital twin technologies, the expanded utilization of automated quality control systems, the spread of comprehensive end-to-end bioprocess automation, and an intensified focus on data-driven production methods.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12704&type=smp

What Drivers Are Shaping The Future Growth Of The Automation In Biopharma Industry Market?

The growing integration of robots within pharmaceutical production is projected to boost the expansion of automation in the biopharmaceutical industry market. These robots are sophisticated automated systems and machinery designed to execute diverse operations in the creation and packaging of pharmaceutical goods. Their widespread use in pharmaceutical manufacturing covers several areas, including secondary packaging, intralogistics, laboratory automation, pick and place functions, the automation of pharmacy processes, and personalized medicine, leading to benefits such as increased productivity, better precision, a lower risk of contamination, and enhanced worker safety. An illustration of this trend is seen in September 2024, when industrial robot installations across the manufacturing sector in Europe saw a 9% rise, reaching an unprecedented 92,393 units, as reported by the International Federation of Robotics, a professional non-profit organization based in Germany. Out of this total, 80% were deployed within the European Union, amounting to 73,534 units, which signifies a 2% increase compared to the prior year. Consequently, the heightened implementation of robots in pharmaceutical production is set to fuel the expansion of automation within the biopharma industry market.

What Segment Types Make Up The Automation In Biopharma Industry Market?

The automation in biopharma industry market covered in this report is segmented –

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

What Key Trends Are Influencing The Development Of The Automation In Biopharma Industry Market?

Leading companies in the biopharma industry market are actively implementing automation, with a specific focus on advancing technological innovations like robotic cell-therapy manufacturing platforms. These platforms are designed to enable the scalable, efficient, and error-reduced production of advanced therapies. A robotic cell-therapy manufacturing platform typically combines mobile robotics, aseptic fluid-handling systems, automated tube welding, and digital process control into a fully closed and modular system, thereby replacing traditional manual bioprocessing methods that rely heavily on labor and open systems. For example, in May 2023, Cellular Origins, a UK-based life sciences automation company, unveiled Constellation, a configurable robotic platform intended for advanced therapy manufacture. This platform integrates autonomous mobile robots, sterile fluid-transfer technology, and modular processing consoles, allowing for seamless incorporation into existing bioprocessing workflows. It boosts space efficiency by 30 times, reduces labor requirements by 16-fold, and cuts production costs by 51%, while simultaneously providing full digital interconnection for quality control and remote monitoring.

Who Are The Key Players Driving Competition In The Automation In Biopharma Industry Market?

Major companies operating in the automation in biopharma industry market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

Read the full automation in biopharma industry market report here:

https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Which Geographic Regions Are Influencing Demand In The Automation In Biopharma Industry Market?

North America was the largest region in the automation in biopharma industry market in 2025. The regions covered in the automation in biopharma industry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Automation In Biopharma Industry Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12704&type=smp

Browse Through More Reports Similar to the Global Automation In Biopharma Industry Market 2026, By The Business Research Company

Bioprocess Automation Global Market Report

https://www.thebusinessresearchcompany.com/report/bioprocess-automation-global-market-report

Pharmacy Automation Global Market Report

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-global-market-report

Pharmacy Automation Systems Global Market Report

https://www.thebusinessresearchcompany.com/report/pharmacy-automation-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795